Trek Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.54M | Buy |
7,005
+13
| +0.2% | +$4.45K | 0.13% | 156 |
|
|
2026
Q1 | $2.46M | Buy |
6,992
+595
| +9% | +$212K | 0.13% | 149 |
|
|
2025
Q4 | $2.09M | Buy |
6,397
+368
| +6% | +$117K | 0.12% | 162 |
|
|
2025
Q3 | $1.7M | Buy |
6,029
+1,322
| +28% | +$383K | 0.1% | 187 |
|
|
2025
Q2 | $1.31M | Sell |
4,707
-477
| -9% | -$135K | 0.09% | 186 |
|
|
2025
Q1 | $1.62M | Buy |
5,184
+1,045
| +25% | +$309K | 0.12% | 143 |
|
|
2024
Q4 | $1.08M | Buy |
4,139
+1,282
| +45% | +$380K | 0.08% | 187 |
|
|
2024
Q3 | $921K | Buy |
2,857
+1,527
| +115% | +$499K | 0.07% | 178 |
|
|
2024
Q2 | $416K | Buy |
1,330
+5
| +0.4% | +$1.47K | 0.03% | 250 |
|
|
2024
Q1 | $377K | Buy |
1,325
+4
| +0.3% | +$1.17K | 0.03% | 264 |
|
|
2023
Q4 | $380K | Sell |
1,321
-592
| -31% | -$161K | 0.03% | 217 |
|
|
2023
Q3 | $514K | Sell |
1,913
-17
| -0.9% | -$4.24K | 0.05% | 175 |
|
|
2023
Q2 | $428K | Buy |
1,930
+480
| +33% | +$111K | 0.04% | 185 |
|
|
2023
Q1 | $351K | Buy |
1,450
+95
| +7% | +$23.3K | 0.03% | 194 |
|
|
2022
Q4 | $356K | Buy |
1,355
+104
| +8% | +$27.9K | 0.04% | 175 |
|
|
2022
Q3 | $282K | Buy |
1,251
+7
| +0.6% | +$1.7K | 0.03% | 176 |
|
|
2022
Q2 | $303K | Buy |
1,244
+48
| +4% | +$11.8K | 0.03% | 175 |
|
|
2022
Q1 | $289K | Sell |
1,196
-97
| -8% | -$22.3K | 0.03% | 180 |
|
|
2021
Q4 | $291K | Sell |
1,293
-239
| -16% | -$50.4K | 0.03% | 162 |
|
|
2021
Q3 | $326K | Sell |
1,532
-270
| -15% | -$62.1K | 0.03% | 148 |
|
|
2021
Q2 | $439K | Buy |
1,802
+124
| +7% | +$30.5K | 0.05% | 119 |
|
|
2021
Q1 | $418K | Buy |
1,678
+235
| +16% | +$56.1K | 0.05% | 110 |
|
|
2020
Q4 | $332K | Buy |
1,443
+15
| +1% | +$3.46K | 0.04% | 119 |
|
|
2020
Q3 | $363K | Hold |
1,428
| – | – | 0.06% | 105 |
|
|
2020
Q2 | $337K | Buy |
1,428
+248
| +21% | +$56.6K | 0.05% | 104 |
|
|
2020
Q1 | $239K | Sell |
1,180
-142
| -11% | -$31K | 0.06% | 80 |
|
|
2019
Q4 | $319K | Sell |
1,322
-212
| -14% | -$46.7K | 0.05% | 85 |
|
|
2019
Q3 | $297K | Sell |
1,534
-1,175
| -43% | -$226K | 0.04% | 98 |
|
|
2019
Q2 | $499K | Buy |
2,709
+865
| +47% | +$155K | 0.09% | 77 |
|
|
2019
Q1 | $350K | Buy |
1,844
+670
| +57% | +$128K | 0.06% | 83 |
|
|
2018
Q4 | $229K | Buy |
+1,174
| New | +$229K | 0.04% | 87 |
|
Other funds holding AMGN
Trek Financial's AMGN Position: Q2 2026 in Review
Trek Financial increased its Amgen (AMGN) stake by 0.19% in Q2 2026, buying an estimated $4.45K and bringing the position to 7,005 shares worth $2.54M. The position accounts for 0.13% of the portfolio, ranked #156.
Trek Financial first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Trek Financial held 7,005 shares of Amgen worth $2.54M as of Q2 2026.
- Trek Financial bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
- Amgen made up 0.13% of Trek Financial's portfolio in Q2 2026, its #156 holding.
- Trek Financial first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.